Vietnam's Pharmaceutical Industry: Examining Other Options

Vietnam's Pharmaceutical Industry: Increased Foreign Room and the Rise of Domestic Production

Frontier and emerging markets (Vietnam)

Dylan Waller

Nomadic Equity

Equity Bottom-Up

<p>Traphaco is currently the best option for listed equity in Vietnam's pharmaceutical industry:</p><ul><li>It is the only one of the top four companies that is not currently fully held by foreign investors</li><li>The company is Vietnam's leading traditional medicine manufacturer, and does not rely heavily on imported materials for production, unlike other companies in this industry</li><li>The pharmaceutical industry is projected to achieve double digit growth throughout 2023</li><li>Vietnam's healthcare industry significantly lags behind its emerging peers in Asia</li></ul>

Traphaco is currently the best option for listed equity in Vietnam's pharmaceutical industry:It is the only one of the top four companies that is not currently fully held by foreign investorsThe company is Vietnam's leading traditional medicine manufacturer, and does not rely heavily on imported materials for production, unlike other companies in this industryThe pharmaceutical industry is projected to achieve double digit growth throughout 2023Vietnam's healthcare industry significantly lags behind its emerging peers in Asia

Domesco Medical Import Export Jsc (DMC VN)

Traphaco Jsc

Vietnam's Pharmaceutical Industry